China Soft Tissue Repair Market Overview, 2030

The STR market focuses on the rehabilitation and repair of injured soft tissues, such as fascia, skin, ligaments, and tendons, across surgical specialties. Its coverage in China includes orthopedics, cardiovascular, dentistry, and cosmetic surgery, with the goals of shortening recovery times, enhancing functional results, and assisting aging and active communities. Globally, there is an increasing need for biologics and robotic-assisted surgeries to aid with trauma care, chronic wound healing, and reconstructive operations. In the 1980s, synthetic meshes and sutures were introduced as soft tissue restoration methods for hernia and tendon repair. Infection, rejection, and poor integration were among the initial difficulties. Biologic grafts such as allografts and xenografts, collagen matrices, and adhesives were used in an effort to address these issues. With government backing for sports medicine and trauma treatment, adoption rates in China increased after 2010. In hospitals and outpatient clinics, STR goods are now utilized for orthopedic trauma, hernia, breast reconstruction, and dental grafting. In essence, STR describes surgical or biological procedures that repair soft tissue integrity. Tissue patches, suture anchors, and biological scaffolds are among the available items. They address actual issues such wound non-healing, persistent pain, and loss of movement. The advantages are Quicker healing, Lower chance of infection, Increased biomechanical strength, Improved tissue regeneration. When combined with minimally invasive procedures and appropriate post-operative treatment, it is highly effective. Innovations that define China's STR industry include Recombinant collagen Type XVII for wound and skin healing, Robots surgical platforms and 3D-printed scaffolds, Gene-modulated matrices and stem cell treatments and Low invasive laparoscopic kits. Trautec and Medprin are examples of companies that are pioneering synthetic biology and regenerative biomaterials, which are supported by advancing YY/T1849 standards and government research and development incentives.

According to the research report, ""China Soft Tissue Repair Market Overview, 2030,"" published by Bonafide Research, the China Soft Tissue Repair market is anticipated to grow at more than 6.09% CAGR from 2025 to 2030. The use of xenografts, biological meshes, and suture less fixation systems is becoming more widespread in Russia. Moscow and St. Petersburg hospitals are testing AI-assisted laparoscopic platforms and robotic-compatible STR kits. There is an increasing need for regenerative treatments for chronic wounds and orthopedic trauma. The following are some of the top STR providers like AlloSource that provides biological matrices and tendon grafts for the treatment of Achilles tendon, rotator cuff, and anterior cruciate ligament ACL injuries, Surgalign that provides fixation systems and biological scaffolds for use in spine and sports medicine, Stryker, Smith & Nephew, Zimmer Biomet, ConMed, Arthrex, and LifeNet Health Offers suture anchors, xenografts, and laparoscopic tools for surgical operations in the fields of dentistry, orthopedics, and reconstruction. These businesses provide STR solutions to address the increasing demand for less invasive procedures, enhance surgical outcomes, and shorten recovery times. Among the main factors driving growth are Increased incidence of sports and trauma injuries, as well as an aging population, Growth of outpatient surgical facilities looking for affordable STR kits. Underpenetrated areas lacking sufficient access to biologics and cutting-edge technology. These elements give rise to opportunities for training programs that are specific to local needs, biological implants, and modular STR solutions. A corporation must acquire the following in order to lawfully sell STR items in Russia, The Roszdravnadzor issued the Registration Certificate RC, Statement of Compliance DoC attesting to technical compliance, National standards require GOST-R Certification, EAC Mark to indicate compliance with the Eurasian Economic Union and A hygiene certificate from Rospotrebnadzor for goods that come into contact with patients.

The soft tissue repair STR in China, broken down by product is divided into tissue matrices, fixation devices, and laparoscopic instruments, all of which are essential for increasing access to cutting-edge surgical treatment. Examples of these tissue matrices are collagen scaffolds, biological grafts allografts, xenografts, and synthetic patches employed in reconstructive surgery, cardiovascular repair, and wound healing. These are used by Chinese establishments such as Xiangya Hospital and West China Hospital for burn treatment, breast reconstruction, and myocardial regeneration. Two-faced hydrogels that minimize inflammation and promote post-operative healing for cardiac tissue repair are among the recent developments. In orthopedic trauma, sports medicine, and dental grafting, suture anchors, tacks, and bone screws are crucial. State-of-the-art fixation systems are used at hospitals like Peking University People's Hospital and Shanghai Sixth People's Hospital for ligament reconstruction, spinal fusion, and joint stabilization. The integration of these devices with robotic platforms and improved recovery protocols is growing. Minimally invasive operations in hernia repair, gynecology, and abdominal surgery are aided by trocar systems, graspers, and energy devices. Reusable, modular kits that lower surgical time and cost are preferred by outpatient centers and specialized clinics. The increasing popularity of robotic-assisted procedures and AI-guided navigation tools is speeding up adoption in metropolitan surgical hubs. With a thriving mix of innovation, infrastructure, and clinical demand, China's STR market is positioned as a regional leader in regenerative and minimally invasive surgical treatment.

China's Soft Tissue Repair STR market, by application is divided into Hernia Repair, Cardiovascular, Skin Repair, Orthopedic, Dental, Breast Reconstruction Repair, Vaginal Sling Procedures and Other applications. With the help of laparoscopic fixation devices, biological and synthetic meshes are commonly used in Chinese hospitals to treat inguinal and abdominal hernias. Cities like Shanghai and Guangzhou are at the forefront of robotic-assisted hernioplasty, which enhances healing and lowers the risk of recurrence, with more than 165,000 hernia surgeries performed there every year. Valve repair, aortic reconstruction, and congenital malformation repair all employ biological and synthetic patches. Fuwait Cardiovascular Center and other hospitals integrate STR into hybrid operating rooms, where biological matrices are favored due to their compatibility and lower rates of reintervention. The use of recombinant collagen technologies is accelerating the rate of skin repair using STR. Trautec pioneered Type XVII collagen, which is utilized in wound dressings and burn therapy. These matrices encourage tissue regeneration and stem cell movement. Ligament and tendon repair utilizes STR products like biologic scaffolds, interference screws, and suture anchors. With the integration of STR into improved recovery protocols and sports medicine rehabilitation, facilities like West China Hospital carry out more than 12,000 orthopedic procedures each year. Bone grafts and collagen membranes promote periodontal regeneration and implant stability. In order to expedite healing and improve aesthetic rehabilitation, dental clinics in Beijing and Shenzhen are increasingly utilizing minimally invasive STR kits. With acellular dermal matrices and mesh supports utilized after mastectomy, the market for breast reconstruction in China is expanding at a CAGR of 7.3%. Although implants are still the most common choice, biological STR materials are becoming more popular due to their integration and lower incidence of capsular contracture. For stress urinary incontinence, biological tapes and mid-urethral slings are utilized.

The market for soft tissue repair STR in China by end use is divided into hospitals and outpatient facilities, each of which has a unique function in the commercialization and clinical uptake of the technology. The majority of complex operations, including hernia repair, breast reconstruction, and cardiovascular treatments, are carried out at urban tertiary hospitals, which are the main source of STR expansion. Integrating biologic grafts, robotic-assisted surgery, and improved recovery regimens are pioneered by institutions like West China Hospital and Xiangya Hospital. The advantages for hospitals are Sophisticated operating infrastructure e.g., robotic systems, laminar flow wards, Interdisciplinary groups providing treatment for trauma, cancer, and reconstruction, large patient volumes make it possible to use premium STR resources, training facilities and R&D supported by the government for advancements in STR. In terms of serving as reference hubs for biological matrices and regenerative therapies, hospitals also function as clinical trial centers, promoting the spread of technology and national STR standards. Specialty clinics and outpatient surgical centers are increasingly utilizing STR in minimally invasive procedures, particularly in orthopedics, dental restoration, and vaginal sling operations. The following services are available at places like Peking University People's Hospital and Shanghai Sixth People's Hospital Day operations performed in large quantities e.g., ACL repair, dental grafting, sling placement, Cost-effective and quick turnaround time for adhesives and STR kits, Increased need for cosmetic and functional restoration with a rapid recovery, Inclusion of STR in the course of treatment for sports medicine and geriatrics. As China's healthcare reforms promote decentralized surgical care, outpatient centers are essential for extending STR access outside of large cities. Outpatient clinics promote accessibility, volume, and minimally invasive adoption, whereas hospitals serve as the hub for innovation and sophisticated STR operations, resulting in a dual-engine growth model for the STR market in China.


Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Soft Tissue Repair Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product
• Tissue Matrix
• Tissue Fixation Products
• Laparoscopic Instruments

By Application
• Hernia Repair
• Cardiovascular
• Skin Repair
• Orthopedic
• Dental
• Breast Reconstruction Repair
• Vaginal Sling Procedures
• Other applications

By End Use
• Hospitals
• Outpatient Facilities Show more